Physician profile
Timothy Ray Kuklo
NPI 1487672440
$1,333,763.06
in general payments reported to CMS, 2019-2025
7 companies · $470K in 2025
The $470K reported for 2025 was more than what 99% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91K · 2020: $62K · 2021: $79K · 2022: $38K · 2023: $80K · 2024: $514K · 2025: $470K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $823K · Consulting Fee: $194K · Travel and Lodging: $41K · Food and Beverage: $5,918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $822,704.61 |
| Consulting Fee | $194,018.72 |
| Travel and Lodging | $41,445.15 |
| Food and Beverage | $5,918.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $1,332,920.59 | 2019-2025 | Other - Miscellaneous, Biologics, Safeop |
| Abyrx, INC | $234.02 | 2019 | |
| Cerapedics INC. | $189.24 | 2021 | |
| Medtronic, INC. | $165.34 | 2023 | Unid_pass |
| Depuy Synthes Sales INC. | $105.04 | 2019-2025 | Vivigen Mis Delivery System, Teligen |
| Zimmer Biomet Holdings, INC. | $104.67 | 2019 | |
| Djo, LLC | $44.16 | 2024 | Cmf |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Kuklo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.